Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.12 | 2e-05 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |